Drug Profile
PG 760564
Alternative Names: PG-760564Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Procter & Gamble
- Class Antirheumatics
- Mechanism of Action P38 mitogen-activated protein kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Rheumatoid arthritis
Most Recent Events
- 30 Oct 2009 Warner Chilcott has acquired the global pharmaceutical business of Procter & Gamble